Sabra Healthcare REIT (NASDAQ:SBRA – Get Free Report) posted its quarterly earnings results on Thursday. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.39 by ($0.28), FiscalAI reports. The business had revenue of $201.35 million for the quarter, compared to the consensus estimate of $201.97 million. Sabra Healthcare REIT had a return on equity of 6.38% and a net margin of 23.50%.
Sabra Healthcare REIT Trading Up 3.3%
NASDAQ SBRA traded up $0.65 during trading hours on Thursday, hitting $20.25. 5,080,241 shares of the company’s stock were exchanged, compared to its average volume of 2,810,229. Sabra Healthcare REIT has a 1-year low of $15.60 and a 1-year high of $20.27. The company has a current ratio of 5.19, a quick ratio of 5.19 and a debt-to-equity ratio of 0.92. The firm has a market cap of $5.05 billion, a price-to-earnings ratio of 28.13 and a beta of 0.67. The stock has a 50-day simple moving average of $19.00 and a 200 day simple moving average of $18.74.
Sabra Healthcare REIT Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 27th. Stockholders of record on Friday, February 13th will be given a dividend of $0.30 per share. The ex-dividend date is Friday, February 13th. This represents a $1.20 annualized dividend and a dividend yield of 5.9%. Sabra Healthcare REIT’s dividend payout ratio is 166.67%.
Hedge Funds Weigh In On Sabra Healthcare REIT
Wall Street Analysts Forecast Growth
Several research firms have recently weighed in on SBRA. Truist Financial upped their price target on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “hold” rating in a report on Tuesday, January 20th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Sabra Healthcare REIT in a research note on Thursday, January 22nd. Jefferies Financial Group reiterated a “buy” rating and set a $22.00 target price on shares of Sabra Healthcare REIT in a report on Monday, December 15th. Wall Street Zen cut Sabra Healthcare REIT from a “hold” rating to a “sell” rating in a research report on Friday, January 23rd. Finally, UBS Group began coverage on Sabra Healthcare REIT in a report on Tuesday, November 18th. They set a “neutral” rating and a $20.00 price objective for the company. Four research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Sabra Healthcare REIT presently has an average rating of “Hold” and an average price target of $21.11.
View Our Latest Research Report on SBRA
About Sabra Healthcare REIT
Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.
Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.
See Also
- Five stocks we like better than Sabra Healthcare REIT
- The DoD just got a new drone supplier
- My Epstein Story
- Think You Missed Silver? You’re Wrong. Here’s Why.
- When to buy gold (mathematically)
- What central banks are doing with gold right now
Receive News & Ratings for Sabra Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
